148 related articles for article (PubMed ID: 6443171)
21. Monoamine oxidase. Its inhibition.
Youdim MB
Mod Probl Pharmacopsychiatry; 1975; 10():65-88. PubMed ID: 1101049
[TBL] [Abstract][Full Text] [Related]
22. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain.
Campbell IC; Robinson DS; Lovenberg W; Murphy DL
J Neurochem; 1979 Jan; 32(1):49-55. PubMed ID: 32233
[No Abstract] [Full Text] [Related]
23. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
Klegeris A; McGeer PL
Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
[TBL] [Abstract][Full Text] [Related]
24. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
Dénes B; Greeff K; Tawfik H
Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
[TBL] [Abstract][Full Text] [Related]
25. Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice.
Feldman JM
Behav Brain Res; 1988 Jul; 29(1-2):147-58. PubMed ID: 2840925
[TBL] [Abstract][Full Text] [Related]
26. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
Copeland ES; Campbell IC; Murphy DL
Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio).
Setini A; Pierucci F; Senatori O; Nicotra A
Comp Biochem Physiol B Biochem Mol Biol; 2005 Jan; 140(1):153-61. PubMed ID: 15621520
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
[TBL] [Abstract][Full Text] [Related]
29. [Monoamine oxidase activity and effect of clorgyline on the polyamine level during hyperoxia in rats].
Goroshinskaia IA; Tsvetnenko EZ; Khodakova AA; Frenkel' ML; Gorkin VZ
Ukr Biokhim Zh (1978); 1986; 58(3):74-7. PubMed ID: 3727040
[TBL] [Abstract][Full Text] [Related]
30. Modification of substrate-inhibitor affinities of human platelet monoamine oxidase B in vitro.
Szutowicz A; Tomaszewicz M; Orsulak PJ
J Biol Chem; 1989 Oct; 264(30):17660-4. PubMed ID: 2509446
[TBL] [Abstract][Full Text] [Related]
31. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
Philips SR; Boulton AA
J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
[No Abstract] [Full Text] [Related]
32. Phospholipid-protein ratio in brain of suckling rabbits treated with an organophosphorus compound.
Maslinska D; Strosznajder J; Zalewska T; Orlewski P
Int J Tissue React; 1984; 6(4):317-22. PubMed ID: 6526604
[TBL] [Abstract][Full Text] [Related]
33. Potentiation of the inhibition of rat liver monoamine oxidase-a by clorgyline after pretreatment with SKF 525A.
Fowler CJ
Med Biol; 1980 Oct; 58(5):285-7. PubMed ID: 7206835
[TBL] [Abstract][Full Text] [Related]
34. Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys.
Staub RA; Gillin JC; Wyatt RJ
Biol Psychiatry; 1980 Jun; 15(3):429-36. PubMed ID: 6769508
[TBL] [Abstract][Full Text] [Related]
35. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
Moskvitina TA; Medvedev AE
Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
[TBL] [Abstract][Full Text] [Related]
36. The inhibition of tyramine oxidation and the tyramine hypertensive response ("cheese effect") may be independent phenomena.
Sandler M; Glover V; Ashford A; Esmail A
J Neural Transm; 1980; 48(4):241-7. PubMed ID: 6775051
[TBL] [Abstract][Full Text] [Related]
37. Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery.
Lang W; Masucci JA; Caldwell GW; Hageman W; Hall J; Jones WJ; Rafferty BM
Anal Biochem; 2004 Oct; 333(1):79-87. PubMed ID: 15351283
[TBL] [Abstract][Full Text] [Related]
38. Cumulative effects of irreversible MAO inhibitors in vivo.
Felner AE; Waldmeier PC
Biochem Pharmacol; 1979 Apr; 28(7):995-1002. PubMed ID: 444293
[No Abstract] [Full Text] [Related]
39. Serotonin depression of local cerebral glucose utilisation after monoamine oxidase inhibition.
Grome JJ; Harper AM
J Cereb Blood Flow Metab; 1985 Sep; 5(3):473-5. PubMed ID: 4030926
[TBL] [Abstract][Full Text] [Related]
40. Demonstration of monoamine oxidase type B in serotonergic and type A in noradrenergic neurons in the cat dorsal pontine tegmentum by an improved histochemical technique.
Kitahama K; Arai R; Maeda T; Jouvet M
Neurosci Lett; 1986 Oct; 71(1):19-24. PubMed ID: 3097589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
